These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19247295)

  • 41. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
    Graul AI; Revel L; Rosa E; Cruces E
    Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Five drugs facing key patent expirations and potential generic entry from April to May 2020.
    Friedman Y
    Pharm Pat Anal; 2020 May; 9(2):41-43. PubMed ID: 32314664
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of the private sector in biotechnology: research and development.
    Feisee L
    Health Matrix Clevel; 2002; 12(2):357-65. PubMed ID: 12430359
    [No Abstract]   [Full Text] [Related]  

  • 44. Biogenerics standoff.
    Herrera S
    Nat Biotechnol; 2004 Nov; 22(11):1343-6. PubMed ID: 15529145
    [No Abstract]   [Full Text] [Related]  

  • 45. A generic problem.
    Hanauer SB
    Nat Clin Pract Gastroenterol Hepatol; 2006 Dec; 3(12):649. PubMed ID: 17130869
    [No Abstract]   [Full Text] [Related]  

  • 46. The infringement exemption.
    Neesemann CE; Hough JE
    Biotechnology (N Y); 1995 Oct; 13(10):1065-6. PubMed ID: 9678913
    [No Abstract]   [Full Text] [Related]  

  • 47. Putting your best mode forward.
    Tsao YR; Tabtiang RK
    Nat Biotechnol; 2000 Oct; 18(10):1113-4. PubMed ID: 11017054
    [No Abstract]   [Full Text] [Related]  

  • 48. World Generic Medicines Congress Americas--a Health Network Communications Conference. 18-21 November 2008, Washington DC, USA.
    Bowman M
    IDrugs; 2009 Feb; 12(2):92-4. PubMed ID: 19204881
    [No Abstract]   [Full Text] [Related]  

  • 49. International Generic Pharmaceutical Alliance - 12th Annual Conference. Part 2.
    Kuhrt K
    IDrugs; 2009 Dec; 12(12):765-9. PubMed ID: 19943218
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patent watch.
    Harrison C
    Nat Rev Drug Discov; 2013 Jan; 12(1):14-5. PubMed ID: 23274462
    [No Abstract]   [Full Text] [Related]  

  • 51. Generics battle brand names over mortality of drug patents.
    Betz R
    J Healthc Resour Manag; 1995 Jul; 13(7):35-7. PubMed ID: 10144008
    [No Abstract]   [Full Text] [Related]  

  • 52. Fresh from the biologic pipeline-2009.
    Sheridan C
    Nat Biotechnol; 2010 Apr; 28(4):307-10. PubMed ID: 20379168
    [No Abstract]   [Full Text] [Related]  

  • 53. Canada wins legal battle to set patent rules.
    Webster P
    CMAJ; 2017 Apr; 189(15):E578. PubMed ID: 28420686
    [No Abstract]   [Full Text] [Related]  

  • 54. Navigating biotechnology's new fiscal opportunities.
    Purcell DJ
    Nat Biotechnol; 1998 May; 16 Suppl():51-3. PubMed ID: 9591271
    [No Abstract]   [Full Text] [Related]  

  • 55. Pfizer slashes R&D.
    Cressey D
    Nature; 2011 Feb; 470(7333):154. PubMed ID: 21307908
    [No Abstract]   [Full Text] [Related]  

  • 56. Investing in risk management.
    Fiscus PW
    Nat Biotechnol; 1997 Jan; 15(1):88-9. PubMed ID: 9035113
    [No Abstract]   [Full Text] [Related]  

  • 57. Kenyan dispute illuminates bioprospecting difficulties.
    Sheridan C
    Nat Biotechnol; 2004 Nov; 22(11):1337. PubMed ID: 15529141
    [No Abstract]   [Full Text] [Related]  

  • 58. The importance of patents to innovation: updated cross-industry comparisons with biopharmaceuticals.
    Cockburn I; Long G
    Expert Opin Ther Pat; 2015 Jul; 25(7):739-42. PubMed ID: 25927945
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lilly goes off Prozac.
    Simons J
    Fortune; 2004 Jun; 149(13):179-80, 182, 184. PubMed ID: 15241951
    [No Abstract]   [Full Text] [Related]  

  • 60. Hatch-waxman changes debated.
    Chahine K
    Nat Biotechnol; 2000 Jul; 18(7):710-1. PubMed ID: 10888831
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.